At Nova Pharma – our innovation is driven by our enterprising and entrepreneurial appetite. We exhibit an ongoing desire and commitment to expand our portfolio, capitalize on market opportunities, and adapt to evolving regulatory environments. With an ever-increasing patient demand for affordable medications, Nova Pharma is strategically positioned to explore new avenues for growth—whether its through partnerships, acquisitions, licensing agreements, or the development of generic medication. This new business development focus is anchored in a commitment to innovation, cost-effectiveness, and compliance, alongside a keen understanding of Australasian market dynamics and consumer needs.
Private label manufacturing is a critical and integral part of our business. We boast over 18 years of experience in managing private label manufacturing for companies in Australia and abroad and our expertise in this area is broad ranging including but not limited to, managing change of batch size, improving costing profiles and adjustments to formulations. Through the number of products already registered in Australia and New Zealand, Nova boasts incredible experience in the process required for development, registration and marketing of both consumer and medicinal products.
Nova Pharma have an experienced in-house regulatory team, who can assist with all the change management processes, and a dedicated distribution team that can deliver the product to your doorstep. We currently have more than 200 registered products as well as over 100 planned products in the pipeline over the next 3 years, so are extremely well-positioned to leverage partnership opportunities.
Nova Pharma is always seeking partners who share a similar passion and ethos as our company.